Man Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64M Buy
69,600
+3,300
+5% +$3.35M 0.12% 186
2025
Q4
$71.3M Buy
66,300
+19,800
+43% +$18.9M 0.12% 178
2025
Q3
$35.5M Sell
46,500
-9,000
-16% -$6.7M 0.06% 333
2025
Q2
$43.3M Sell
55,500
-19,000
-26% -$14.8M 0.08% 269
2025
Q1
$61.5M Sell
74,500
-5,900
-7% -$4.91M 0.16% 144
2024
Q4
$62.1M Buy
80,400
+32,100
+66% +$26.6M 0.16% 140
2024
Q3
$42.8M Buy
48,300
+20,300
+73% +$18.3M 0.11% 234
2024
Q2
$25.4M Buy
28,000
+11,400
+69% +$9.12M 0.06% 362
2024
Q1
$12.9M Buy
16,600
+6,500
+64% +$4.63M 0.03% 594
2023
Q4
$5.89M Buy
+10,100
New +$5.9M 0.02% 875
2021
Q4
Sell
-1,600
Closed -$370K 2034
2021
Q3
$370K Buy
1,600
+1,500
+1,500% +$370K ﹤0.01% 1607
2021
Q2
$23K Buy
+100
New +$20.1K ﹤0.01% 1914

Other funds holding LLY

Man Group's LLY Position: Q1 2026 in Review

Man Group increased its Eli Lilly (LLY) stake by 17% in Q1 2026, buying an estimated $61.8M and bringing the position to 422,016 shares worth $388M. The position accounts for 0.7% of the portfolio, ranked #11.

Man Group first reported a position in LLY in Q1 2018 and has held it in 30 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Man Group held 422,016 shares of Eli Lilly worth $388M as of Q1 2026.
  • Man Group bought 60,956 Eli Lilly shares in Q1 2026, an estimated $61.8M.
  • Eli Lilly made up 0.7% of Man Group's portfolio in Q1 2026, its #11 holding.
  • Man Group first reported a position in Eli Lilly in Q1 2018 and has held it in 30 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.